Novartis AG ADR sell Barclays PLC
Start price
22.02.25
/
50%
€103.50
Target price
22.02.26
-
Performance (%)
32.85%
End price
23.02.26
€137.50
Summary
This prediction ended on 23.02.26 with a price of €137.50. The price for Novartis AG ADR massively increased, which is bad news for the SELL prediction by Barclays_PLC. Dividends of €3.87 are taken into consideration when calculating the performance. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Novartis AG ADR | -3.497% | -3.497% | 31.429% |
| iShares Core DAX® | -6.016% | -4.595% | 1.274% |
| iShares Nasdaq 100 | 0.511% | 0.164% | 14.573% |
| iShares Nikkei 225® | -7.156% | -2.215% | 28.107% |
| iShares S&P 500 | -0.257% | -0.841% | 10.196% |
Comments by Barclays_PLC for this prediction
In the thread Novartis AG ADR diskutieren
Novartis AG (NYSE: NVS) had its "underweight" rating re-affirmed by analysts at Barclays PLC.
Ratings data for NVS provided by MarketBeat
In the thread Trading Novartis AG ADR
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten